Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Revision: v3.3.4 to the history and removed Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:11:29.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a new site revision entry, Revision: v3.3.3, to the history and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.
    Difference
    0.1%
    Check dated 2025-12-23T09:09:22.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page header now displays Revision: v3.3.2, replacing Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T17:07:51.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The record history now shows new sections including Contacts/Locations, Eligibility, Arms and Interventions, Study Design, Study Description, and Study Status, expanding visibility of core trial details. A government funding notice was removed.
    Difference
    1.0%
    Check dated 2025-11-17T15:06:27.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Old and new screenshots show the same list of study record versions, with no additions or deletions to the study content; differences are only UI chrome in the Record History view. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:32:47.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Updated operating status notice and version to v3.2.0; removes previous v3.1.0 reference and directs users to current status sources.
    Difference
    10%
    Check dated 2025-10-05T10:28:41.000Z thumbnail image

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.